Evidence map›Paper›PMID 42646559›Full record

ArticleMedical sciences (Basel, Switzerland)2026

Intermediate-Dose Tinzaparin Versus Low-Dose Enoxaparin as Thromboprophylaxis in Hospitalized Internal Medicine Patients.

Aimilios Kaklamanos, Vasileios Serepisios, Sofia Chelioti, Kalliopi Zervakou, George Christodoulou, Abraham Pouliakis, Konstantina Mikelopoulou, Daphnie Germanou, Ilias Tsinokou, Dimitrios Dorotheos Papadakis and 2 more

Abstract readComparative Study
In one paragraph

Article in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Aimilios KaklamanosDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Vasileios SerepisiosDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0009-0002-9894-1142
Sofia CheliotiDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0009-0004-3094-3162
Kalliopi ZervakouDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
George ChristodoulouDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Abraham Pouliakis2nd Department of Pathology, University Hospital "Attikon", National and Kapodistrian University of Athens, 12461 Athens, Greece.ORCID 0000-0002-0074-3619
Konstantina MikelopoulouDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Daphnie GermanouDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0009-0000-7731-126X
Ilias TsinokouDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Dimitrios Dorotheos PapadakisDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0003-4422-1262
Christos TsironisDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Theodoros AndroutsakosDepartment of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0003-2556-6230

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EnoxaparinFibrinolytic AgentsHeparin, Low-Molecular-WeightThrombosisAgedAged, 80 and overAnticoagulantsDose-Response Relationship, DrugFemaleHemorrhageHospitalizationHumansInternal MedicineMaleMiddle AgedTinzaparinAnticoagulantsEnoxaparinFibrinolytic AgentsHeparin, Low-Molecular-WeightTinzaparinbleedingenoxaparinthrombosis prophylaxistinzaparin

Identifiers

PMID42646559
PMCPMC13515995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.